Here’s yet another exhibit for the jury to consider in the case of Sanity v. Sell-Side Research: Ladies and Gentlemen, I present Barclays Bank on Amylin Pharmaceuticals: Firm is introducing long term estimates for AMLN from 2011-2020 which assume exenatide LAR approval and launch in the US by 3Q10 and by 3Q11 in Europe. In…
Barclays
Hot Links: Bad Hair Day
Stuff I’m Reading this Morning… STOP! Don’t cash out your 401(k) before reading this from Karl Denninger. (Market-Ticker) Here’s a great list of the basic books that all value investors should read. (ValuePlays) Cali has company: New York State is running out of cash. (InvestingContrarian) Frankly, America, Wall Street Really Doesn’t Give a Damn. (NYP)…
